Ignite Creation Date:
2025-12-24 @ 1:15 PM
Ignite Modification Date:
2026-02-28 @ 5:33 AM
Study NCT ID:
NCT02750995
Status:
COMPLETED
Last Update Posted:
2020-11-25
First Post:
2016-04-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML
Sponsor:
Daniel El Fassi
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AZACTA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |